Overall Survival Data | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
Real-World Overall Survival | IBRANCE® (palbociclib) | Safety Info
JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology
Kaplan-Meier curves for overall survival.
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) - Annals of Oncology
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer - Journal of Geriatric Oncology
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy - European Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
Sirtex - Overall Survival
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG
Overall survival for oncology drugs approved for genomic indications - European Journal of Cancer